📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Remedy Pharmaceuticals

1.1 - Company Overview

Remedy Pharmaceuticals Logo

Remedy Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage small molecule drug therapies for acute central nervous system disorders, developing treatments that target NCCa-ATP channels in traumatic brain injury, stroke, and spinal cord injury, including RP-1127, an intravenous glyburide inhibitor acting through type-1 sulfonylurea antagonism.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Remedy Pharmaceuticals

Chase Therapeutics Logo

Chase Therapeutics

HQ: United States Website
  • Description: Provider of early-stage, product-based specialty pharmaceuticals, including CTC-413 for symptomatic and neuroprotective treatment of Parkinson’s disease and related disorders (Phase 2), CTC-501 for symptomatic treatment of major depressive disorder (Phase 2), and a Parkinson’s disease bioassay for diagnosis and immediate-response outcome measurement in clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chase Therapeutics company profile →
Diagnamed Logo

Diagnamed

HQ: Canada Website
  • Description: Provider of digital health AI platforms and tools to improve brain health, including BRAIN AGE AI for estimating brain age and assessing cognitive decline using EEG and machine learning; CERVAI Brain Health AI for assessments and research with generative AI; Dr. GenAI, a healthcare chatbot; PalGPT.ai for brain health applications; and FormGPT.io for healthcare applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Diagnamed company profile →
Cypress Bioscience Logo

Cypress Bioscience

HQ: United States Website
  • Description: Provider of therapeutics and personalized medicine services to facilitate individualized patient care, addressing needs such as isolated areas of pain, rheumatology, and physical medicine and rehabilitation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cypress Bioscience company profile →
Quadrant Biosciences Logo

Quadrant Biosciences

HQ: United States Website
  • Description: Provider of epigenetic diagnostics focused on early detection of neurological disorders, offering: a virtual pediatric clinic for autism evaluations via telehealth; molecular diagnostics for COVID-19, autism and Parkinson’s; autism assessment workflow software; and wastewater monitoring for SARS-CoV-2 and other pathogens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quadrant Biosciences company profile →
Cantabio Pharmaceuticals Logo

Cantabio Pharmaceuticals

HQ: United States Website
  • Description: Provider of preclinical biotechnology drug discovery research and therapeutic development focused on neurodegenerative and metabolic diseases, developing small-molecule DJ-1 protein-targeting therapeutics for Parkinson’s and other conditions and Tau protein-targeting therapeutics for Alzheimer’s and related tauopathies, integrating biophysics and novel technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cantabio Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Remedy Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Remedy Pharmaceuticals

2.2 - Growth funds investing in similar companies to Remedy Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Remedy Pharmaceuticals

4.2 - Public trading comparable groups for Remedy Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Remedy Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Remedy Pharmaceuticals

What does Remedy Pharmaceuticals do?

Remedy Pharmaceuticals is a provider of clinical-stage small molecule drug therapies for acute central nervous system disorders, developing treatments that target NCCa-ATP channels in traumatic brain injury, stroke, and spinal cord injury, including RP-1127, an intravenous glyburide inhibitor acting through type-1 sulfonylurea antagonism.

Who are Remedy Pharmaceuticals's competitors?

Remedy Pharmaceuticals's competitors and similar companies include Chase Therapeutics, Diagnamed, Cypress Bioscience, Quadrant Biosciences, and Cantabio Pharmaceuticals.

Where is Remedy Pharmaceuticals headquartered?

Remedy Pharmaceuticals is headquartered in United States.

How many employees does Remedy Pharmaceuticals have?

Remedy Pharmaceuticals has 1,000 employees 🔒.

When was Remedy Pharmaceuticals founded?

Remedy Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Remedy Pharmaceuticals in?

Remedy Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Remedy Pharmaceuticals

Who are the top strategic acquirers in Remedy Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Remedy Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Remedy Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Remedy Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Remedy Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Remedy Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Remedy Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Remedy Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Remedy Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Remedy Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Remedy Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Remedy Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Remedy Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Remedy Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Remedy Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Remedy Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Remedy Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Remedy Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Remedy Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Remedy Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Remedy Pharmaceuticals

Launch login modal Launch register modal